Number of the records: 1
imunosupresiva
SYS d007166 LBL 01890nz--a2200325n--4500 003 CZ-PrNML 005 20240206162307.5 008 990101-n-ancnnbaba----------||-ana-----d 035 $a (DNLM)D007166 040 $a ABA008 $b cze $f czmesh 072 $a D27. $x 505. $x 696. $x 477. $x 656 150 $a imunosupresiva $2 czmesh 450 $w i $a Immunosuppressant $i UF 450 $w i $a Immunosuppressants $i UF 450 $w i $a Immunosuppressive Agent $i UF 550 $w g $a imunologické faktory $7 upol_us_auth*d007155 550 $w h $a inhibitory interleukinu $7 upol_us_auth*d000088902 550 $w h $a inhibitory interleukinu-6 $7 upol_us_auth*d000093242 550 $w h $a inhibitory komplementu $7 upol_us_auth*d051056 550 $w h $a modulátory receptorů sfingosin-1-fosfátu $7 upol_us_auth*d000081243 550 $w h $a mTOR inhibitory $7 upol_us_auth*d000091203 550 $w h $a myeloablativní agonisté $7 upol_us_auth*d019653 550 $w i $a antilymfocytární sérum $i RT $7 upol_us_auth*d000961 550 $w i $a antirevmatika $i RT $7 upol_us_auth*d018501 680 $i Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. 688 $a 66(64) 750 -2
$a Immunosuppressive Agents $2 czmesh 980 $x M 982 $a 1
Number of the records: 1